JENNIFER BARTLEY: Open Payments
NPI 1326477423 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 18 payments from 11 companies in 2025. Trend: 2023 $2,041 · 2024 $809 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $62 |
| PFIZER INC. | 2 | $54 |
| ABBVIE INC. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Novo Nordisk Inc | 1 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Amgen Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Dexcom G6 Transmitter, MOUNJARO, TRELEGY ELLIPTA, PREVNAR 20, QULIPTA, Ozempic, TZIELD, EVENITY.
Industry payments across CA — which companies pay providers there.
